Morgan Stanley Sop Hi A Genetics Sa Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Sop Hi A Genetics Sa stock. As of the latest transaction made, Morgan Stanley holds 35,210 shares of SOPH stock, worth $144,008. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,210

Previous 36,136 2.56%

Holding current value

$144,008

Previous $119,000 8.4%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	SELL	$2.66 - $3.29 $2,463 - $3,046	-926 Reduced 2.56%	35,210 $109,000
Q1 2025 May 15, 2025	SELL	$2.89 - $4.5 $2,788 - $4,342	-965 Reduced 2.6%	36,136 $119,000
Q4 2024 Feb 14, 2025	SELL	$3.07 - $3.99 $30,991 - $40,279	-10,095 Reduced 21.39%	37,101 $113,000
Q3 2024 May 14, 2025	SELL	$3.19 - $4.8 $41,090 - $61,828	-12,881 Reduced 21.44%	47,196 $172,000
Q3 2024 Nov 14, 2024	SELL	$3.19 - $4.8 $41,090 - $61,828	-12,881 Reduced 21.44%	47,196 $172,000
Q2 2024 May 14, 2025	BUY	$4.46 - $5.55 $102,472 - $127,516	22,976 Added 61.93%	60,077 $275,000
Q2 2024 Oct 17, 2024	BUY	$4.46 - $5.55 $60,343 - $75,091	13,530 Added 29.07%	60,077 $275,000
Q2 2024 Aug 14, 2024	BUY	$4.46 - $5.55 $60,343 - $75,091	13,530 Added 29.07%	60,077 $275,000
Q1 2024 Oct 17, 2024	SELL	$4.21 - $5.62 $56,961 - $76,038	-13,530 Reduced 22.52%	46,547 $229,000
Q1 2024 Aug 16, 2024	BUY	$4.21 - $5.62 $2,071 - $2,765	492 Added 1.07%	46,547 $229,000
Q1 2024 May 15, 2024	BUY	$4.21 - $5.62 $2,071 - $2,765	492 Added 1.07%	46,547 $229,000
Q4 2023 Aug 16, 2024	SELL	$2.5 - $4.87 $35,055 - $68,287	-14,022 Reduced 23.34%	46,055 $216,000
Q4 2023 Feb 13, 2024	SELL	$2.5 - $4.87 $5,490 - $10,694	-2,196 Reduced 4.55%	46,055 $216,000
Q3 2023 Nov 15, 2023	BUY	$2.3 - $4.58 $31,537 - $62,800	13,712 Added 39.7%	48,251 $122,000
Q2 2023 Aug 14, 2023	BUY	$3.84 - $5.3 $230 - $318	60 Added 0.17%	34,539 $154,000
Q1 2023 May 15, 2023	BUY	$1.98 - $5.49 $28,809 - $79,879	14,550 Added 73.01%	34,479 $171,000
Q4 2022 Feb 14, 2023	SELL	$1.71 - $2.98 $725,199 - $1.26 Million	-424,093 Reduced 95.51%	19,929 $41,000
Q3 2022 Nov 14, 2022	BUY	$2.63 - $5.1 $1.09 Million - $2.11 Million	413,267 Added 1343.74%	444,022 $1.17 Million
Q2 2022 Oct 27, 2022	BUY	$2.46 - $7.91 $20,730 - $66,657	8,427 Added 37.74%	30,755 $111,000
Q2 2022 Aug 15, 2022	BUY	$2.46 - $7.91 $20,730 - $66,657	8,427 Added 37.74%	30,755 $111,000
Q1 2022 Oct 27, 2022	SELL	$7.31 - $15.6 $61,601 - $131,461	-8,427 Reduced 27.4%	22,328 $173,000
Q1 2022 May 13, 2022	BUY	$7.31 - $15.6 $33,143 - $70,730	4,534 Added 25.48%	22,328 $173,000
Q4 2021 Feb 14, 2022	SELL	$12.35 - $18.8 $1.04 Million - $1.59 Million	-84,475 Reduced 82.6%	17,794 $251,000
Q3 2021 Nov 15, 2021	BUY	$15.18 - $19.77 $1.55 Million - $2.02 Million	102,269 New	102,269 $1.79 Million

Others Institutions Holding SOPH

# of Institutions

Shares Held

18.5M

Call Options Held

Put Options Held

View Full List

About SOPHiA GENETICS SA

Ticker SOPH
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 64,153,700
Market Cap $262M
Description
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory...

More about SOPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account